Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1033天前
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 777天前
Swiss Market Ends Modestly Lower

Swiss Market Ends Modestly Lower

The Switzerland market closed on a weak note on Monday, after languishing in negative territory right through the day's trading session as investors remained hesitant to pick up stocks, choosing to wait for some crucial economic data, and the monetary policy announcements from several central banks.
RTTNews | 3小時33分鐘前
European Stocks Close Mostly Higher On Easing Trade Tensions

European Stocks Close Mostly Higher On Easing Trade Tensions

European stocks closed on a positive note on Monday with investors focusing on the upcoming monetary policy announcements from several central banks, including the European Central Bank, the Federal Reserve and the Bank of Japan, and following the developments on U.S.-China trade front.
RTTNews | 3小時49分鐘前
German Business Confidence Improves On Stronger Expectations: Ifo

German Business Confidence Improves On Stronger Expectations: Ifo

Business morale in Germany rebounded more than expected in October as companies' expectations were the strongest in over three-and-a-half years, though they gave a weaker assessment of the current situation for a third month in a row, results of a closely watched survey by the ifo institute showed on Monday.
RTTNews | 6小時6分鐘前
Bay Street May Open On Mixed Note

Bay Street May Open On Mixed Note

The Canadian market is likely to open on a mixed note on Monday. Easing worries about U.S.-China trade tensions may aid sentiment, while weak commodity prices could weigh on resources stocks and limit market's upside, if any.
RTTNews | 9小時18分鐘前